Anti-Breast Cancer Compound Library

Description: - A unique collection of 2440 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；- Targets include HER-2, VEGF, EGFR, PARP, CDK4/6, HSP, PD-1, SET7/9, BRCA, etc.；- Some compounds have been in market or in clinical trials;- Detailed compound information with structure, target, and biological activity description；- NMR and HPLC validated to ensure high purity and quality.

• SKU: TGML2191-50uL
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: L2191-50uL
• Package Unit: 50 μL
• Quantity Unit: STK